Abstract
The liver fluke, Fasciola hepatica, infects a wide range of mammals including humans and leads to chronic disease. Like other helminths, F. hepatica migrates and survives in the host tissues after penetrating the intestinal wall to enter the peritoneal cavity, and then migrates through the liver before finally inhabiting the bile ducts. To avoid the antihelminthic immune response during migration, F. hepatica releases excretory–secretory products (FhESP) that exert various immunomodulatory effects, such as alternative macrophage activation or programmed cell death induction. Here, we describe the currently available techniques for studying macrophage activation and apoptotic cell death triggered by purified FhESP originating from the adult F. hepatica fluke.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Mehmood K, Zhang H, Sabir AJ, Abbas RZ, Ijaz M, Durrani AZ, Saleem MH, Ur Rehman M, Iqbal MK, Wang Y, Ahmad HI, Abbas T, Hussain R, Ghori MT, Ali S, Khan AU, Li J (2017) A review on epidemiology, global prevalence and economical losses of fasciolosis in ruminants. Microb Pathog 109:253–262
Ruyssers NE, De Winter BY, De Man JG, LoukasA, Herman AG, Pelckmans PA, Moreels TG (2008). Worms and the treatment of inflammatory bowel disease: are molecules the answer? Clin Dev Immunol 2008:567314. https://doi.org/10.1155/2008/567314
Navarro S, Ferreira I, Loukas A (2013) The hookworm pharmacopoeia for inflammatory diseases. Int J Parasitol 43:225–231
Shepherd C, Navarro S, Wangchuk P, Wilson D, Daly NL, Loukas A (2015) Identifying the immunomodulatory components of helminthes. Parasite Immunol 37(6):293–303
Cervi L, Rubinstein H, Masih DT (1996) Involvement of excretion–secretion products from Fasciola hepatica inducing suppression of the cellular immune responses. Vet Parasitol 61:97–111
Cervi L, Masih DT (1997) Inhibition of spleen cell proliferative response to mitogens by excretory–secretory antigens of Fasciola hepatica. Int J Parasitol 27:573–579
Cervi L, Rossi G, Cejas H, Masih DT (1998) Fasciola hepatica-induced immune suppression of spleen mononuclear cell proliferation: role of nitric oxide. Clin Immunol Immunopathol 87:145–154
Cervi L, Rossi G, Masih DT (1999) Potential role for excretory–secretory forms of glutathione-S-transferase (GST) in Fasciola hepatica. Parasitology 119:627–633
Cervi L, Cejas H, Masih DT (2001) Cytokines involved in the immunosuppressor period in experimental fasciolosis in rats. Int J Parasitol 31:1467–1473
Chapman CB, Mitchell GF (1982) Proteolytic cleavage of immunoglobulin by enzymes released by Fasciola hepatica. Vet Parasitol 11:165–178
Duffus WP, Franks D (1980) In vitro effect of immune serum and bovine granulocytes on juvenile Fasciola hepatica. Clin Exp Immunol 41:430–440
Heffernan M, Smith A, Curtain D, McDonnell S, Ryan J, Dalton JP (1991) Characterisation of a cathepsin-B proteinase released by Fasciola hepatica (liver fluke). Biochem Soc Trans 19:27S
Masih DT, Cervi L, Casado JM (1996) Modification of accessory activity of peritoneal cells from Fasciola hepatica infected rats. Vet Immunol Immunopathol 539:257–268
Flynn RJ, Irwin JA, Olivier M, Sekiya M, Dalton JP, Mulcahy G (2007) Alternative activation of ruminant macrophages by Fasciola hepatica. Vet Immunol Immunopathol 120:31–40
Flynn RJ, Mulcahy G (2008) Possible role for toll-like receptors in interaction of Fasciola hepatica excretory/secretory products with bovine macrophages. Infect Immun 76:678–684
Donnelly S, Stack CM, O’Neill SM, Sayed AA, Williams DL, Dalton JP (2008) Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J 22:4022–4032
Walsh KP, Brady MT, Finlay CM, Boon L, Mills KHG (2009) Infection with a helminth parasite attenuates autoimmunity through TGF-b mediated suppression of Th17 and Th1 responses. J Immunol 183:1577–1586
Guasconi L, Serradell MC, Garro AP, Iacobelli L, Masih DT (2011) C-type lectins on macrophages participate in the immunomodulatory response to Fasciola hepatica products. Immunology 133:386–396
Guasconi L, Chiapello LS, Masih DT (2015) Fasciola hepatica excretory-secretory products induce CD4+T cell anergy via selective up-regulation of PD-L2 expression on macrophages in a Dectin-1 dependent way. Immunobiology 220(7):934–939
Motran CC, Silvane L, Chiapello LS, Theumer MG, Ambrosio LF, Volpini X, Celias DP, Cervi L (2018) Helminth infections: recognition and modulation of the immune response by innate immune cells. Front Immunol 9:664. https://doi.org/10.3389/fimmu.2018.00664
Serradell MC, Guasconi L, Cervi L, Chiapello LS, Masih DT (2007) Excretory-secretory products from Fasciola hepatica induce eosinophil apoptosis by a caspase-dependent mechanism. Vet Immunol Immunopathol 117:197–208
Serradell MC, Guasconi L, Masih DT (2009) Involvement of a mitochondrial pathway and key role of hydrogen peroxide during eosinophil apoptosis induced by excretory-secretory products from Fasciola hepatica. Mol Biochem Parasitol 163(2):95–106
Guasconi L, Serradell MC, Masih DT (2012) Fasciola hepatica products induce apoptosis of peritoneal macrophages. Vet Immunol Immunopathol 148(3-4):359–363
Diaz A, Espino AM, Marcet R, Otero O, Torres D, Finlay CM et al (1998) Partial characterization of the epitope on excretory–secretory products of Fasciola hepatica recognized by monoclonal antibody ES78. J Parasitol 84:55–61
Zhang X, Goncalves R, Mosser DM (2008) The isolation and characterization of murine macrophages. Curr Protoc Immunol. Chapter 14, Unit–14.1. https://doi.org/10.1002/0471142735.im1401s83
Ray A, Dittel BN (2010) Isolation of mouse peritoneal cavity cells. J Vis Exp 35:e1488. https://doi.org/10.3791/1488
Mosser DM, Zhang X (2008) Activation of murine macrophages. Curr Protoc Immunol 83(1):14.2.1–14.2.8
Corraliza IM, Campo ML, Soler G, Modollel M (1994) Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 174:231–235
Chiapello LS, Baronetti JL, Garro AP, Spesso MF, Masih DT (2008) Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway. Int Immunol 20(12):1527–1541
Nicoletti I, Migliorati M, Pagliacci M, Grignani F, Riccardi CA (1991) Rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271
Martin SJ, Reutelingsperger CP, McGahon AJ et al (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545
Koh CM (2013) Preparation of cells for microscopy using cytospin. Methods Enzymol 533:235–240
Acknowledgments
This work was supported by SECyT-UNC No: 30720150100933CB, FONCyT PICT No 2015-1425 and CONICET, PIP No: GI 112201 501002 60. We would like to thank Dr. Paul Hobson, a native speaker, for revision of the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Guasconi, L., Serradell, M.C., Masih, D.T., Chiapello, L.S. (2020). Immunomodulatory Effect of Fasciola hepatica Excretory–Secretory Products on Macrophages. In: Cancela, M., Maggioli, G. (eds) Fasciola hepatica. Methods in Molecular Biology, vol 2137. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0475-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0475-5_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0474-8
Online ISBN: 978-1-0716-0475-5
eBook Packages: Springer Protocols